Weiss Multi-Strategy Advisers’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-10,452
| Closed | -$141K | – | 826 |
|
2020
Q4 | $141K | Sell |
10,452
-726
| -6% | -$9.79K | ﹤0.01% | 618 |
|
2020
Q3 | $132K | Buy |
11,178
+124
| +1% | +$1.46K | ﹤0.01% | 516 |
|
2020
Q2 | $163K | Buy |
+11,054
| New | +$163K | ﹤0.01% | 500 |
|
2020
Q1 | – | Sell |
-10,500
| Closed | -$254K | – | 622 |
|
2019
Q4 | $254K | Sell |
10,500
-9,500
| -48% | -$230K | ﹤0.01% | 491 |
|
2019
Q3 | $384K | Hold |
20,000
| – | – | 0.01% | 406 |
|
2019
Q2 | $591K | Sell |
20,000
-15,000
| -43% | -$443K | 0.02% | 338 |
|
2019
Q1 | $1.66M | Sell |
35,000
-5,000
| -13% | -$238K | 0.04% | 285 |
|
2018
Q4 | $1.44M | Buy |
40,000
+9,882
| +33% | +$357K | 0.06% | 217 |
|
2018
Q3 | $1.85M | Sell |
30,118
-4,882
| -14% | -$301K | 0.05% | 273 |
|
2018
Q2 | $2.36M | Sell |
35,000
-10,000
| -22% | -$675K | 0.06% | 243 |
|
2018
Q1 | $2.44M | Sell |
45,000
-10,000
| -18% | -$542K | 0.08% | 234 |
|
2017
Q4 | $3.29M | Buy |
55,000
+5,000
| +10% | +$299K | 0.08% | 192 |
|
2017
Q3 | $2.43M | Hold |
50,000
| – | – | 0.09% | 230 |
|
2017
Q2 | $2.63M | Sell |
50,000
-16,000
| -24% | -$841K | 0.11% | 206 |
|
2017
Q1 | $2.99M | Hold |
66,000
| – | – | 0.12% | 177 |
|
2016
Q4 | $2.5M | Buy |
66,000
+16,000
| +32% | +$606K | 0.12% | 151 |
|
2016
Q3 | $1.89M | Buy |
+50,000
| New | +$1.89M | 0.12% | 182 |
|
2015
Q2 | – | Sell |
-10,000
| Closed | -$313K | – | 501 |
|
2015
Q1 | $313K | Buy |
+10,000
| New | +$313K | 0.01% | 356 |
|